Literature DB >> 30672626

Corticospinal excitability can discriminate quadriceps strength indicative of knee function after ACL-reconstruction.

Stephan G Bodkin1, Grant E Norte2, Joseph M Hart1.   

Abstract

PURPOSE: To investigate relationships between quadriceps strength and neural activity, and to establish a clinical threshold of corticospinal excitability able to discriminate between patients with quadriceps strength indicative of satisfactory and unsatisfactory knee function after ACLR.
METHODS: A total of 29 patients following primary, unilateral ACL-reconstruction (11 female, 23.2 ± 8.1 years of age, 7.3 ± 2.5 months since surgery) participated. Subjective knee function was quantified using the International Knee Documentation Committee (IKDC) subjective evaluation. Peak isokinetic knee extensor torque was assessed at 90°/s. Quadriceps corticospinal excitability was quantified via active motor threshold (AMT, %2-Tesla) using transcranial magnetic stimulation during a 5% maximal voluntary isometric contraction of the quadriceps. Pearson's r correlations were used to assess the relationship between peak knee extensor torque and AMT. Receiver operating characteristic (ROC) curves were used to establish a threshold of (a) mass-normalized peak knee extensor torque to discriminate satisfactory knee function (IKDC ≥ 75.9%), and (b) AMT to discriminate quadriceps strength indicative of satisfactory knee function. Likelihood ratios (LR) and the magnitude of change in pre-post-test probability were calculated for each threshold.
RESULTS: Active motor threshold was negatively correlated with mass-normalized peak knee extensor torque (r = -0.503, P = 0.005). Knee extensor torque ≥1.23 Nm/kg was an excellent discriminator of satisfactory knee function (AUC = 0.890, P = 0.002; (+)LR = 9.56). An AMT ≤50.5% was an excellent discriminator of quadriceps strength indicative of satisfactory knee function following ACLR (AUC = 0.839, P = 0.005; (+)LR = 23.75).
CONCLUSION: Lower corticospinal excitability was associated with lower quadriceps strength. An AMT above 50.5% was found to decrease the probability of having satisfactory knee strength by over 62%.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  anterior cruciate ligament; arthrogenic muscle inhibition; muscle function; patient acceptable symptom state; return to play

Mesh:

Year:  2019        PMID: 30672626     DOI: 10.1111/sms.13394

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  5 in total

1.  Assessment of Quadriceps Corticomotor and Spinal-Reflexive Excitability in Individuals with a History of Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis.

Authors:  Justin L Rush; Neal R Glaviano; Grant E Norte
Journal:  Sports Med       Date:  2021-01-05       Impact factor: 11.136

2.  Corticomotor function is associated with quadriceps rate of torque development in individuals with ACL surgery.

Authors:  Sarah A Scheurer; David A Sherman; Neal R Glaviano; Christopher D Ingersoll; Grant E Norte
Journal:  Exp Brain Res       Date:  2020-01-02       Impact factor: 1.972

3.  Thigh-Muscle and Patient-Reported Function Early After Anterior Cruciate Ligament Reconstruction: Clinical Cutoffs Unique to Graft Type and Age.

Authors:  David Sherman; Thomas Birchmeier; Christopher M Kuenze; Craig Garrison; Joseph Hannon; James Bothwell; Curtis Bush; Grant E Norte
Journal:  J Athl Train       Date:  2020-08-01       Impact factor: 2.860

4.  Evaluation of motor cortical excitability using evoked torque responses: A new tool with high reliability.

Authors:  Aastha K Dharia; Adam Gardi; Amanda K Vogel; Aviroop Dutt-Mazumder; Chandramouli Krishnan
Journal:  J Neurosci Methods       Date:  2020-11-12       Impact factor: 2.390

5.  How does anterior cruciate ligament reconstruction affect the functioning of the brain and spinal cord? A systematic review with meta-analysis.

Authors:  Kazandra M Rodriguez; Riann M Palmieri-Smith; Chandramouli Krishnan
Journal:  J Sport Health Sci       Date:  2020-07-21       Impact factor: 7.179

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.